Key result
Commercial 5% plasma protein fraction solutions demonstrate a vasodilator effect.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May warrant caution with commercial plasma protein fractions in unstable patients; leaves open confirmation in prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bland et al. (1974) studied this question. Commercial 5% plasma protein fraction solutions demonstrate a vasodilator effect.
Synapse has enriched 10 related papers. Consider them for comparative context: